Physician profile
Thomas D Matthews
NPI 1679516629
$1,165.08
in general payments reported to CMS, 2019-2025
9 companies · $54.20 in 2025
The $54.20 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.15 · 2020: $55.63 · 2022: $145 · 2023: $802 · 2024: $71.08 · 2025: $54.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $490 · Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $489.74 |
| Food and Beverage | $437.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $725.67 | 2023 | Amistem |
| Stryker Corporation | $107.35 | 2022-2025 | Alphavent, Inspace, Tornier Perform Reversed Glenoid |
| Heraeus Medical, LLC. | $94.39 | 2022-2023 | Palacos |
| Zimmer Biomet Holdings, INC. | $91.18 | 2019-2023 | Gel-One Cross-Linked Hyaluronate |
| Elite Orthopedics, LLC | $55.63 | 2020 | |
| Smith+Nephew, INC. | $31.36 | 2019-2025 | Pico |
| Ferring Pharmaceuticals INC. | $27.10 | 2023-2024 | Euflexxa |
| Ethicon US, LLC | $21.03 | 2024 | Stratafix |
| Wright Medical Technology, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.